Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study.
Scherpereel A, Berghmans T, Lafitte JJ, Colinet B, Richez M, Bonduelle Y, Meert AP, Dhalluin X, Leclercq N, Paesmans M, Willems L, Sculier JP; European Lung Cancer Working Party (ELCWP).
Scherpereel A, et al. Among authors: dhalluin x.
Eur Respir J. 2011 Jan;37(1):129-35. doi: 10.1183/09031936.00037310. Epub 2010 Jun 7.
Eur Respir J. 2011.
PMID: 20530048
Free article.
Clinical Trial.